z-logo
open-access-imgOpen Access
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19
Author(s) -
Emmanuel Lafont,
Hélène Péré,
David Lebeaux,
Geoffrey Cheminet,
Éric Thervet,
R. Guillemain,
Adrien Flahault
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac253
Subject(s) - covid-19 , virology , betacoronavirus , medicine , sars virus , pandemic , pneumonia , coronavirus infections , infectious disease (medical specialty) , outbreak , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom